Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : UK's MHRA Says Moderna Vaccine Can Be Used As Safe, Effective Booster Dose

09/14/2021 | 12:37pm EDT

Sept 14 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency (MHRA):

* MHRA STATEMENT ON COVID-19 BOOSTER VACCINES

* UK'S MHRA - REGULATORY UPDATES BY THE MHRA TODAY ON THE COVID-19 BOOSTER VACCINE PROGRAMME FOR WINTER 2021 TO 2022

* UK'S MHRA - CHM EXPERTS CONCLUDED MODERNA VACCINE CAN BE USED AS SAFE, EFFECTIVE BOOSTER DOSE, INCLUDING IN A HALF DOSE


© Reuters 2021
All news about MODERNA, INC.
02:10aMODERNA : U.S. To Lift COVID-19 Travel Ban To Allow Fully Vaccinated Travelers
AQ
10/20MODERNA : US FDA OKs Booster Shots for Moderna, Johnson & Johnson's COVID-19 Jabs
MT
10/20EMEA MORNING BRIEFING : Stocks to Struggle as -2-
DJ
10/20MODERNA : Announces FDA Authorization of a Booster Dose of Moderna's COVID-19 Vaccine in t..
BU
10/20FDA Authorizes Booster Shots for Moderna, J&J Vaccines; Greenlights Mixing Brands
MT
10/20U.s. fda clears moderna and j&j boosters, backs 'mix-and-match' strategy
RE
10/20MODERNA : U.S. FDA clears Moderna and J&J boosters, backs 'mix-and-match' strategy
RE
10/20MODERNA : J&J Covid-19 Vaccine Boosters Reportedly Receive FDA Authorization, Bloomberg Sa..
MT
10/20MODERNA : US regulators allow mixing of COVID-19 shots for boosters and clear booster Mode..
AQ
10/20MODERNA : U.S. administers 410.2 mln doses of COVID-19 vaccines - CDC
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 335 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 11,2x
Yield 2021 -
Capitalization 134 B 134 B -
EV / Sales 2021 5,97x
EV / Sales 2022 5,24x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 333,01 $
Average target price 299,31 $
Spread / Average Target -10,1%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.218.76%134 418
LONZA GROUP AG29.18%59 339
IQVIA HOLDINGS INC.40.38%48 194
SEAGEN INC.-0.17%31 811
CELLTRION, INC.-39.00%25 446
ALNYLAM PHARMACEUTICALS, INC.56.82%24 224